Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,645 shares at $54.40 ($90K) on 2009-02-17, disclosed to the SEC on 2009-02-19.
Scheduled sale ($90k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.40 | 417 | $23K | 25.2% |
| 2 | $54.94 | 1,228 | $67K | 74.8% |
| Total | $54.80 avg | 1,645 | $90K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |